Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Inhalation vs Oral for COVID-19
NCT04510233Phase 2Unknown
- Sponsor
- Tanta University
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Status: unknown.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04510233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04510233.